http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4777161-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75692a38a2eff0ee47b923b5ecb6bc79
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
filingDate 1985-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fefeed5a0f555d1849d73aa44697fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_747a58dc757bcd6d39bf6ed60a6fd818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2775e72c1342bd6f9264ffeeb89e518a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21707bf47521fd48cec70673eb4a37fd
publicationDate 1988-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4777161-A
titleOfInvention Medicaments favoring the properties of blood flow and their use in therapeutics
abstract The medicaments of the invention contain in their active principle, oligosaccharides of low molecular weight corresponding to or including heparin fragments.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5130143-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4990502-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004058940-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03018032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4841041-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5646130-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004038932-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5023078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008119438-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5084564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071570-B2
priorityDate 1984-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4486420-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2035349-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12302986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18634851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234451716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53860086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226642242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226719139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128013850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135955169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11116353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226719140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87064977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226465838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411183

Total number of triples: 57.